Literature DB >> 16310051

Secretory IgA and mucin-mediated biofilm formation by environmental strains of Escherichia coli: role of type 1 pili.

R Randal Bollinger1, Mary Lou Everett, Shaina D Wahl, Yu-Huei Lee, Paul E Orndorff, William Parker.   

Abstract

Recent studies suggest the importance of secretory IgA (SIgA) and mucin in the mediation of biofilm formation by commensal bacteria within the mammalian gut. Studies using a variety of strains of Escherichia coli have indicated that the interaction between E. coli and SIgA is dependent on the type 1 pilus. In this study, the importance of the pilus in SIgA-mediated biofilm formation by a laboratory strain (MG1655) and environmental (fecal) strains of E. coli was evaluated. Transient expression of the type 1 pilus by the laboratory strain of E. coli failed to facilitate SIgA-mediated biofilm formation, whereas constitutive expression of the type 1 pilus by the laboratory strain was sufficient. In contrast, transient expression of the type 1 pilus was sufficient to facilitate SIgA-mediated biofilm formation by environmental isolates. The "threshold" for mucin-mediated biofilm formation appeared to be lower than that for SIgA-mediated biofilm formation, perhaps reflecting disparate roles of mucin and SIgA in mediating biofilm formation in the gut. These studies also provide the first procedures for the growth of bacterial biofilms on live epithelial cells in vitro, an important development that may facilitate future studies on the effects of bacterial biofilms on epithelial cells.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16310051     DOI: 10.1016/j.molimm.2005.02.013

Source DB:  PubMed          Journal:  Mol Immunol        ISSN: 0161-5890            Impact factor:   4.407


  39 in total

Review 1.  Role of the gut microbiota in defining human health.

Authors:  Kei E Fujimura; Nicole A Slusher; Michael D Cabana; Susan V Lynch
Journal:  Expert Rev Anti Infect Ther       Date:  2010-04       Impact factor: 5.091

Review 2.  Innate signaling networks in mucosal IgA class switching.

Authors:  Alejo Chorny; Irene Puga; Andrea Cerutti
Journal:  Adv Immunol       Date:  2010       Impact factor: 3.543

3.  DNA supercoiling and the Lrp protein determine the directionality of fim switch DNA inversion in Escherichia coli K-12.

Authors:  Arlene Kelly; Colin Conway; Tadhg O Cróinín; Stephen G J Smith; Charles J Dorman
Journal:  J Bacteriol       Date:  2006-08       Impact factor: 3.490

4.  Biofilms in the normal human large bowel: fact rather than fiction.

Authors:  R Randal Bollinger; Andrew S Barbas; Errol L Bush; Shu S Lin; William Parker
Journal:  Gut       Date:  2007-10       Impact factor: 23.059

Review 5.  The regulation of IgA class switching.

Authors:  Andrea Cerutti
Journal:  Nat Rev Immunol       Date:  2008-06       Impact factor: 53.106

Review 6.  Immune-directed support of rich microbial communities in the gut has ancient roots.

Authors:  Larry J Dishaw; John P Cannon; Gary W Litman; William Parker
Journal:  Dev Comp Immunol       Date:  2014-06-28       Impact factor: 3.636

Review 7.  Manipulation of the glycan-specific natural antibody repertoire for immunotherapy.

Authors:  J Stewart New; R Glenn King; John F Kearney
Journal:  Immunol Rev       Date:  2016-03       Impact factor: 12.988

Review 8.  Escherichia coli biofilms.

Authors:  C Beloin; A Roux; J M Ghigo
Journal:  Curr Top Microbiol Immunol       Date:  2008       Impact factor: 4.291

9.  Circulating Human CD27-IgA+ Memory B Cells Recognize Bacteria with Polyreactive Igs.

Authors:  Magdalena A Berkowska; Jean-Nicolas Schickel; Christina Grosserichter-Wagener; Dick de Ridder; Yen Shing Ng; Jacques J M van Dongen; Eric Meffre; Menno C van Zelm
Journal:  J Immunol       Date:  2015-07-06       Impact factor: 5.422

10.  Epithelial cells augment barrier function via activation of the Toll-like receptor 2/phosphatidylinositol 3-kinase pathway upon recognition of Salmonella enterica serovar Typhimurium curli fibrils in the gut.

Authors:  Gertrude O Oppong; Glenn J Rapsinski; Tiffanny N Newman; Jessalyn H Nishimori; Steven G Biesecker; Çagla Tükel
Journal:  Infect Immun       Date:  2012-12-03       Impact factor: 3.441

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.